文献速递青光眼

青光眼代谢组学研究:系统综述

Metabolomics in Glaucoma: A Systematic Review.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2021-01-01

该系统综述检索了截至2020年11月11日PubMed和Web of Science上关于人类青光眼代谢组学的研究,共纳入18篇文章,其中13篇聚焦开角型青光眼(OAG)。结论指出OAG患者存在一系列代谢紊乱,但需更多研究验证现有发现并探索不同生物体液间的潜在重叠。

要点

  • 共纳入18篇人类青光眼代谢组学研究,其中13篇针对开角型青光眼(OAG)。
  • 通路富集分析提示氨基酸代谢在OAG病理生理中起主要作用。

核心结论

  • 综述总结了青光眼生物标志物鉴定的现有代谢组学研究,指出OAG患者存在一系列代谢紊乱,为青光眼分子机制变化提供了信息。
  • 需要额外研究验证现有发现,未来研究需探索不同生物体液之间的潜在重叠。

研究设计与样本

  • 系统综述,检索PubMed和Web of Science上2020年11月11日之前发表的人类青光眼代谢组学研究。
  • 纳入标准为评估任何类型青光眼生物标志物并采用基于质谱或核磁共振的代谢组学方法的研究。
  • 共纳入18篇文章,其中13篇聚焦开角型青光眼(OAG)。
  • 使用MetaboAnalyst 3.0进行通路富集分析和拓扑分析以生成青光眼相关代谢特征的全局视图。

主要发现

  • 通路分析提示氨基酸代谢在OAG病理生理中起主要作用,并揭示了不同生物样本之间的代谢特征。

临床怎么用

  • 综述提供的OAG相关代谢物谱和氨基酸代谢通路信息,可为未来青光眼生物标志物研究和机制探索提供参考。
  • 现有发现尚需验证,临床暂不能基于这些代谢物进行青光眼诊断或分型。

局限性

  • 现有发现需要额外研究验证。
  • 未来研究需要探索不同生物体液之间的潜在重叠。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Glaucoma remains a poorly understood disease, and identifying biomarkers for early diagnosis is critical to reducing the risk of glaucoma-related visual impairment and blindness. The aim of this review is to provide current metabolic profiles for glaucoma through a summary and analysis of reported metabolites associated with glaucoma. METHODS: We searched PubMed and Web of Science for metabolomics studies of humans on glaucoma published before November 11, 2020. Studies were included if they assessed the biomarkers of any types of glaucoma and performed mass spectrometry-based or nuclear magnetic resonance-based metabolomics approach. Pathway enrichment analysis and topology analysis were performed to generate a global view of metabolic signatures related to glaucoma using the MetaboAnalyst 3.0. RESULTS: In total, 18 articles were included in this review, among which 13 studies were focused on open-angle glaucoma (OAG). Seventeen metabolites related to OAG were repeatedly identified, including seven amino acids (arginine, glycine, alanine, lysine, methionine, phenylalanine, tyrosine), two phosphatidylcholine (PC aa C34:2, PC aa C36:4), three complements (acetylcarnitine, propionylcarnitine, butyrylcarnitine), carnitine, glutamine, hypoxanthine, spermine, and spermidine. The pathway analysis implied a major role of amino metabolism in OAG pathophysiology and revealed the metabolic characteristics between different biological samples. CONCLUSIONS: In this review, we summarize existing metabolomic studies related to glaucoma biomarker identification and point out a series of metabolic disorders in OAG patients, providing information on the molecular mechanism changes in glaucoma. Additional studies are needed to validate existing findings, and future research will need to explore the potential overlap between different biological fluids.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Wang Y, Hou XW, Liang G, et al. Metabolomics in Glaucoma: A Systematic Review. Invest Ophthalmol Vis Sci. 2021. PMID: 33956051. doi:10.1167/iovs.62.6.9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。